Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
3rd Nuclear Medicine dpt of AUTh I. Iakovou
Assist. Professor
Μοριακή απεικόνιση και θεραπεία
3rd Nuclear Medicine dpt of AUTh I. Iakovou
Assist. Professor
I have no conflict of interest
George de Hevesy 1911
Anatomical vs Molecular
Imaging
Anatomical vs Molecular
Imaging
Hybrid imaging
(S) PET / CT (MRI) Υβριδική απεικόνιση
WHO classification of neuroendocrine tumours
The European Neuroendocrine Society (ENETS) grading system
Treatment guidelines
March 2015
March 2015
March 2015
March 2015
• Non specific tumor imaging 18F-FDG • Substrate –based imaging 18F-FDOPA, 11C-5HTP • Receptor-based imaging 68Ga-DOTA- TOC
- NOC - TATE
However, 18F-FDG-PET is currently not used for the study of neuroendocrine tumors (NETs) in a routine basis because these tumors are generally slow-growing and, accordingly, have low glycolytic activity compared to other malignancies, which may lead to a low sensitivity for 18F-FDG-PET.
Clin Cancer Res 2010
SSR imaging
FDG imaging
Clin Cancer Res 2010
Clin Cancer Res 2010
11C
11C
+
-
Oberg K - Theranostics (2012) Cured carcinoid of the small intestine ?
Oberg K - Theranostics (2012)
Mid gut carcinoid tumor with negative CI
Fiebrich H et al. Circulation 2008;118:1602-1604
111In-Octreoscan 18F-FDOPA Multislice CT
Metastatic glucagonoma of pancreas
Hybrid imaging
«Το τεχνήτιο του PET»
68Ga-Dotatoc
111In-Octreoscan
68Ga-Dotatoc
111In-Octreoscan
68Ga-Dotatoc
Non functional NET with multiple liver metastases (CUP). The primary tumor was detected by PET/CT in the tail of pancread and later confirmed by EUS and biopsy
Non functional NET with multiple liver metastases (CUP). The primary tumor was detected by PET/CT in the tail of pancread and later confirmed by EUS and biopsy
111In-pentetreotide scan, planar + SPECT
Normal
Liver meastasis
Binds to:
SSTR 2 with high affinity,
SSTR 3 and SSTR 5 with low affinity
Πυρηνική Ιατρική & πραγματικότητα στην Ελλάδα
Πυρηνική Ιατρική & πραγματικότητα στην Ελλάδα
18FDG,
11CHTP, 18FDOPA 68Ga DOTATOC
T.S. ♀ 69 yrs
Unknown primary
Liver meta BSST (++), Ki67<5
Transcatheter Arterial ChemoEmbolization
Ask NMdpt for PRRT
Case 1
CT1 7/2012 CT2 10/2012
ΣΥΜΠΕΡΑΣΜΑ: Σε σύγκριση με το σπινθηρογράφημα ήπατος-σπληνός και την CT απεικόνιση του
ήπατος (οι οποίες και αναδεικνύουν πληθώρα δευτερογενών βλαβών) δυο μόνο από
αυτές (στο ΔΕ ηπατικό λοβό) εκφράζουν παθολογικά υποδοχείς σωματοστατίνης
(κατά κύριο λόγο τύπου ΙΙ).
Η πολύ χαμηλή πρόσληψη του ραδιοφαρμάκου δεν καθιστά την ασθενή
υποψήφια για θεραπεία με επισημασμένα ανάλογα σωματοστατίνης.
ΣΥΜΠΕΡΑΣΜΑ: Σε σύγκριση με το σπινθηρογράφημα ήπατος-σπληνός και την CT απεικόνιση του
ήπατος (οι οποίες και αναδεικνύουν πληθώρα δευτερογενών βλαβών) δυο μόνο από
αυτές (στο ΔΕ ηπατικό λοβό) εκφράζουν παθολογικά υποδοχείς σωματοστατίνης
(κατά κύριο λόγο τύπου ΙΙ).
Η πολύ χαμηλή πρόσληψη του ραδιοφαρμάκου δεν καθιστά την ασθενή
υποψήφια για θεραπεία με επισημασμένα ανάλογα σωματοστατίνης.
R.A. ♂ 49 yrs
Small Cell Lung Cancer
BTTF1 (-), CD56 (+), Ki67 2
Chemo ttt
Ask NMdpt for PRRT
Case 2
Left lung
Posterior & middle mediastenum
&
Right anteroposterior mediastenum
↓
ratio ↑ ↑, Krenning score 3
X.T. ♀ 59 yrs
Carcinoid of small intestine (ressetced)
Liver meta B grade G2 (ENETS), Ki67 4%
Ask NMdpt for PRRT
Case 3
Octreoscan JULY
CT JULY
CT NOVEMBER
Octreoscan DECEMBER
JULY DECEMBER
CT NOVEMBER CT JULY
7/2012 12/2012
Hofman MS. Australian Doctor, Mar. 16, 2011.
M.A. ♀ 58 yrs
2007: mDTC ressetced, RAI, WB(-) Tg(-) AbTg(-)
Ask NMdpt for PRRT
Case 4
2008: liver meta + symptomatology, CT (-)
2003 carcinoid in small intestine ressected, no mitotic activity
2009: octreoscan (+) liver, abdomen
2011: progression (liver CT + symptoms)
M.A. ♀ 58 yrs
Case 4
2003 carcinoid in small intestine ressected, no mitotic activity
2007: mDTC ressected, RAI, WB(-)
ablation
M.A. ♀ 58 yrs
2007: mDTC ressected, RAI, WB(-)
Ask NMdpt for PRRT
Case 4
2008: liver meta + symptomatology, CT brain (-)
2003 carcinoid in small intestine ressected, no mitotic activity
2009: octreoscan (+) liver, abdomen
M.A. ♀ 58 yrs
2007: mDTC resetced, RAI, WB(-)
Case 4
2008: liver meta + symptomatology, CT (-)
2003 carcinoid in small intestine ressected, no mitotic activity
2009: octreoscan (SST+) liver, abdomen
Myoset + SSA_LAR
OK
M.A. ♀ 58 yrs
2007: mDTC resetced, RAI, WB(-)
Case 4
2008: liver meta + symptomatology, CT (-)
2003 carcinoid in small intestine ressected, no mitotic activity
2009: octreoscan (+) liver, abdomen
2011: progression (liver CT + symptoms)
carvoplatine
CT stable disease, chromogranine ↑ ↑(665), ↑ diarrhea
M.A. ♀ 58 yrs
2007: mDTC ressected, RAI, WB(-)
Ask NMdpt for PRRT
Case 4
2008: liver meta + symptomatology, CT (-)
2003 carcinoid in small intestine ressected, no mitotic activity
2009: octreoscan i (+) liver, abdomen
2011: progression (liver CT + symptoms)
11/2011: octreoscan ii
liver
abdomen
ratio ↑ ↑, Krenning score 3
2009 2011
3 x 200 mCi 177Lu-DOTATATE
05/2012 07/2012 09/2012
1st 177Lu 05/2012
2nd 177Lu 07/2012
3rd 177Lu 09/2012
3 x 200 mCi 177Lu-DOTATATE
05/2012
01/2013
M.A. ♀ 58 yrs
2007: mDTC resetced, RAI, WB(-)
Ask NMdpt for PRRT
Case 4
2008: liver meta + symptomatology, CT (-)
2003 carcinoid in small intestine resetced, no mitotic avtivity
2009: ocreoscan i (+) liver, abdomen
2011: progression (liver CT + symptoms)
11/2011: octreoscan ii
Tu Relaps
200 mCi 177Lu-DOTATATE
200 mCi 177Lu-DOTATATE
4th cycle
5th cycle
relaps
S. G. ♂ 64 yrs
Unknown primary (small intestine?)
Case 5
Liver, abdominal , bone meta + symptomatology
History of interstitial lung disease
2011: progression (liver CT + symptoms)
S. G. ♂ 64 yrs
Unknown primary (small intestine?)
Case 5
Liver, abdominal , bone meta + symptomatology
History of interstitial lung disease
2011: progression (liver CT + symptoms)
S. G. ♂ 64 yrs
Unknown primary (small intestine?)
Ask NMdpt for PRRT
Case 5
Liver, abdominal , bone meta + symptomatology
History of interstitial lung disease
2011: progression (liver CT + symptoms)
3 x 120 mCi 90Y-DOTATOC
05/2012 07/2012 09/2012
Onalta®
1st 90Y 05/2012 2nd 90Y 07/2012
3rd 90Y 09/2012
S. G. ♂ 64 yrs
Unknown primary (small intestine?)
Ask NMdpt for PRRT
Case 5
Liver, abdomianl , bone meta + symptomatology
History of interstitial lung disease
2011: progression (liver CT + symptoms)
Symptoms remission, ↓↓ Cga
Died 01/2013 pulmonary infection
S. G. ♂ 64 yrs
Unknown primary (small intestine?)
Ask NMdpt for PRRT
Case 5
Liver, abdomianl , bone meta + symptomatology
History of interstitial lung disease
2011: progression (liver CT + symptoms)
Symptoms remission, ↓↓ Cga
Died 01/2013 pulmonary infection
S. G. ♂ 64 yrs
Unknown primary (small intestine?)
Ask NMdpt for PRRT
Case 5
Liver, abdomianl , bone meta + symptomatology
History of interstitial lung disease
2011: progression (liver CT + symptoms)
Symptoms remission, ↓↓ Cga
Died 01/2013 pulmonary infection
90 Y DOTATOC
Α. G. ♀ 64 yrs
Unknown primary
Ask NMdpt for SIRT
Case 6
Symptomatology ± controlled with SSA_LAR
Liver meta B grade G3 (ENETS), Ki67 23%
Selective Internal RadioTherapy
Nuklearmedizin
Universitätsklinikum des Saarlandes
3rd Nuclear Medicine dpt
Aristotle University
3,3 GBq 90Y- TheraSphere®
TheraSphere consists of insoluble 20-30 0m glass spheres with
90Y as an integral constituent of the glass matrix
Right liver lobe SIRT
4 months after
1st SIRT in RL
2nd SIRT
LL
2nd SIRT
LL
2nd SIRT
LL
SIRT
G. G. ♂ 64 yrs
Ask NMdpt for PRRT
Case 7
Liver, abdomianl , bone meta + symptomatology
bronchopulmonary neuroendocrine tumor
2014: progression (liver CT + symptoms)
G. G. ♂ 64 yrs
Ask NMdpt for PRRT
Case 7
Liver, abdomianl , bone meta + symptomatology
bronchopulmonary neuroendocrine tumor
2014: progression (liver CT + symptoms)
G.G♂ 64 yrs
Case 7
Liver, abdomianl , bone meta + symptomatology
bronchopulmonary neuroendocrine tumor
2014: progression (liver CT + symptoms)
DO NOT Ask
Case 8 malignant paraganglioma
SSR SPECT/CT
Case 8 malignant paraganglioma
G.G♂ 64 yrs
Case 8
Liver, abdomianl , bone meta + symptomatology
bronchopulmonary neuroendocrine tumor
2014: progression (liver CT + symptoms)
DO NOT Ask
C o n c l u s i o n s
- No OCTREOSCAN TEKTROTYD
- No PET/CT 68Ga DOTATOC, 18FDG,
11CHTP, 18FDOPA
-15,000 Euro for one (1) therapy session !!!
- γραφειοκρατεία (± 2 months, indication)
C o n c l u s i o n s
Success’ condition?
Cooperation and specialization
Young Women from the Village (Gustave Courbet)
Jeune orpheline au cimetière (Eugène Delacroix)
Woman Eating (Duane Hanson)
Romanticism vs. Realism vs. Hyperrealism
111In DOTA gastrin
Χαμηλή νεφρική πρόσληψη Ελκυστική
(-) τάχιστη ενζυματική αποδόμιση
συγχoρήγηση με αναστολέα
ενδοπεπτιδάσης (phosphoramidon)
Tumor uptake μεχρι και 72 p.i.
με χαμηλή νεφρική πρόσληψη
111In DOTA gastrin
Χαμηλή νεφρική πρόσληψη Ελκυστική
(-) τάχιστη ενζυματική αποδόμιση
συγχoρήγηση με αναστολέα
ενδοπεπτιδάσης (phosphoramidon)
Tumor uptake μεχρι και 72 p.i.
με χαμηλή νεφρική πρόσληψη